In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
In two weeks' time, independent mutual fund directors will gather in New York to discuss issues related board composition and diversity in the boardroom. The directors—and ...
Investment Company Institute CEO Eric Pan came out swinging on Tuesday, delivering keynote remarks to 2024 Investment Management Conference attendees in which he railed against "over-regulation" and vowed ...
A senior member of the Securities and Exchange Commission's Division of Investment Management on Monday indicated to mutual fund industry professionals that the Commission will not ...
Today is International Women's Day, and there's plenty to celebrate in the mutual fund governance space. Women have made strides in recent years in getting into ...